Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.60 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.43 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.37 |
| ▸ | ALB | P02768 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26020751 | 0.96 | GLP1R (0.61) | GLP1RNOD1GLO1EPHX2FOLH1 | |
| SCHEMBL21242829 | 0.91 | GLP1R (0.67) | GLP1RNOD1GLO1EPHX2FOLH1 | |
| SCHEMBL21099709 | 0.91 | GLP1R (0.67) | GLP1RNOD1GLO1EPHX2FOLH1 | |
| SCHEMBL19786714 | 0.89 | GLP1R (0.68) | GLP1RNOD1 | |
| SCHEMBL17551913 | 0.89 | GLP1R (0.62) | GLP1RNOD1EPHX2FOLH1 | |
| SCHEMBL25455652 | 0.89 | GLP1R (0.65) | GLP1RNOD1GLO1 | |
| SCHEMBL16182595 | 0.89 | GLP1R (0.65) | GLP1RNOD1GLO1 | |
| SCHEMBL12807352 | 0.89 | GLP1R (0.65) | GLP1RNOD1GLO1 | |
| SCHEMBL23874254 | 0.89 | GLP1R (0.56) | GLP1RNOD1GLO1FOLH1 | |
| SCHEMBL24253205 | 0.89 | GLP1R (0.54) | GLP1RNOD1GLO1FOLH1ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022032353-A1 | RADIOPHARMACEUTICALS, USES THEREOF, AND METHODS FOR THE PRODUCTION THEREOF | Clarity Pharmaceuticals Ltd (AU) | 2022-02-17 | — | — | WO | disclosed |